更加迫在眉睫的问题与控制原始捐赠和源于诱导多能干细胞的组织培养有关。
More immediate concerns have to do with control of the original donation and tissue grown from iPS cells.
新型合作关系会认可细胞提供者和实验人员双方对于培养和维持诱导多能干细胞的贡献。
New partnerships could acknowledge the contributions of both the cell provider and the laboratories that grow and sustain ips cell lines.
新型合作关系会认可细胞提供者和实验人员双方对于培养和维持诱导多能干细胞的贡献。
New partnerships could acknowledge the contributions of both the cell provider and the laboratories that grow and sustain ips cell lines.
应用推荐